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Bacterial pathogens use a range of protein secretion systems to colonize their host. One recent
addition to this arsenal is the type VI secretion system (T6SS), which is found in many Gram-
negative bacteria. The T6SS involves 12–15 components, including a ClpV-like AAA
+ ATPase.
Moreover, the VgrG and Hcp components have been proposed to form a puncturing device,
based on structural similarity to the tail spike components gp5/gp27 and the tail tube component
gp19 of the T4 bacteriophage, respectively. Another T6SS component shows similarity to a T4
phage protein, namely gp25. The gp25 protein has been proposed to have lysozyme activity.
Other T6SS components do not exhibit obvious similarity to characterized T4 phage components.
The genome of Pseudomonas aeruginosa contains three T6SS gene clusters. In each cluster a
gene encoding a putative member of the gp25-like protein family was identified, which we called
HsiF. We confirmed this similarity by analysing the structure of the P. aeruginosa HsiF proteins
using secondary and tertiary structure prediction tools. We demonstrated that HsiF1 is crucial for
the T6SS-dependent secretion of Hcp and VgrG. Importantly, lysozyme activity of HsiF proteins
was not detectable, and we related this observation to the demonstration that HsiF1 localizes to
the cytoplasm of P. aeruginosa. Finally, our data showed that a conserved glutamate, predicted to
be required for proper HsiF folding, is essential for its function. In conclusion, our data confirm the
central role of HsiF in the T6SS mechanism, provide information on the predicted HsiF structure,
and call for reconsideration of the function of gp25-like proteins.
INTRODUCTION
Pathogenic bacteria adopt different lifestyles while infecting
their host (Merrell & Falkow, 2004). A broad arsenal of
virulence factors ensures bacterial survival and successful
establishment of acute or chronic infections. Protein secre-
tion systems are the weapons of choice in the course of an
infection (Bleves et al., 2010). In many cases, including that
of the opportunistic pathogen Pseudomonas aeruginosa,t h e
type III secretion system (T3SS) has been linked to increased
mortality, persistence, relapse, and higher bacterial burdens
in acutely infected patients (Hauser et al., 2002; Hauser,
2009; Roy-Burman et al., 2001). Another secretion system
has been the subject of intense investigation during the last
five years: the type VI secretion system (T6SS). In several
studies, T6SS genes have been induced upon colonization of
the host (Bingle et al., 2008; Cascales, 2008; Filloux et al.,
2008). In contrast to the T3SS, the P. aeruginosa T6SS has
been shown to be associated with chronic infection. It has
been shown that sera of cystic fibrosis patients chronically
infected with P. aeruginosa contain antibodies directed
against the T6SS component Hcp, which suggests that the
T6SS is highly active in this context (Mougous et al., 2006).
Furthermore, high-throughput screening for P. aeruginosa
mutants attenuated in a rat model of chronic respiratory
infection has demonstrated that T6SS genes are essential for
bacterial survival (Potvin et al.,2 0 0 3 ) .H o w e v e r ,i th a s
recently been proposed that one of the P. aeruginosa T6SSs is
required to compete with other bacteria, in particular by
allowing the release of a set of toxins named Tse1–3 (Hood
et al., 2010; Schwarz et al., 2010). In a recent study, it was
shown that both Tse1 and Tse3 can be delivered to the
periplasm of recipient bacteria, and that these proteins are
able to hydrolyse peptidoglycan (Russell et al., 2011).
In P. aeruginosa,t h r e eT6SS gene clusters have been iden-
tified, namely H1- to H3-T6SS (Filloux et al., 2008). Whereas
H1-T6SS gene expression is controlled by the RetS/LadS
signalling pathway (Goodman et al., 2004; Records & Gross,
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been proposed to be under control of the quorum-sensing
circuitry (Lesic et al., 2009). The number of genes and the
genetic organization vary from one cluster to the other
(Filloux et al., 2008), but a set of genes encoding T6SS core
components has been identified. One of these is the clpV
gene, which encodes a protein from the AAA
+ ATPase
family. In Vibrio cholerae, ClpV has been shown to modulate
the assembly of tubular complexes formed by two compo-
nents of the V. cholerae T6SS machinery, namely VipA and
VipB (Bo ¨nemann et al., 2009, 2010; Filloux, 2009).
Little is known about the function of genes contained in
T6SS clusters and whether all are needed for T6SS function.
In Edwardsiella tarda, a systematic study has been per-
formed, in which it has been found that 13 out of the 16
predicted T6SS components (Evp) are required for EvpP
secretion (Zheng & Leung, 2007). Furthermore, how the
T6SS machinery assembles and promotes transport of
proteins across the bacterial cell envelope is also largely
unknown. Finally, which proteins are secreted via the T6SS
is poorly understood and has been clearly reported only in
a few cases, e.g. the three T6SS substrates Tse1–3, recently
identified in P. aeruginosa (Hood et al., 2010).
In most Gram-negative bacteria carrying a T6SS, two core
T6SS components are present as T6SS substrates, namely
the VgrG and Hcp proteins (Mougous et al., 2006; Pukatzki
et al., 2007). Intriguingly, the most remarkable feature of
VgrG and Hcp proteins is their structural resemblance to
the tail components of the T4 bacteriophage (Leiman et al.,
2009, 2010). VgrG proteins resemble the gp27/gp5 tri-
meric complex used by the phage to puncture the bacterial
cell membrane and initiate DNA injection. The puncturing
device sits on top of the phage tail tube used by the phage to
inject DNA into bacteria (Leiman et al., 2009). Interestingly,
Hcp proteins show structural similarity to gp19, which forms
the tail tube. This resemblance is supported by the fact that
Hcp proteins form hexameric rings in vitro. These structures
have a central channel of 40 A ˚ in diameter (Mougous et al.,
2006) and assemble into nanotubes (Ballister et al., 2008;
Leiman et al.,2 0 0 9 ) .T h e s eo b s e r v a t i o n ss u g g e s tt h a tt h e
T6SS forms an inverted puncturing device, perforating
the bacterial cell envelope from the inside to the outside
(Pukatzki et al., 2009). There is therefore a possibility that
T6SS substrates are secretedthrough the Hcp tubeorinteract
directly with VgrG proteins at the tip of the tube. In this way
they could be transported through the bacterial membrane
concomitantly with the VgrG proteins (Hachani et al., 2011).
The latter possibility is based on the observation that some
VgrG proteins carry C-terminal domains displaying specific
activity, such as actin remodelling activity in VgrG1 from V.
cholerae (Ma et al., 2009) and Aeromonas hydrophila (Suarez
et al., 2010). Consequently, these C-terminal extensions are
considered effector proteins of the T6SS, though they are
covalently linked to one of its components. In P. aeruginosa,
three VgrG proteins are co-regulated with the H1-T6SS
cluster, namely VgrG1a (PA0091), VgrG1b (PA0095) and
VgrG1c (PA2685) (Hood et al., 2010; Mougous et al., 2006).
Whereas VgrG1a and VgrG1c are secreted in an H1-T6SS-
dependent manner,VgrG1bisstillsecretedinaclpV1mutant
and has been found to be secreted independently of all three
P. aeruginosa T6SSs (Hachani et al., 2011).
In this study, we have investigated the role of an as-yet-
uncharacterized P. aeruginosa T6SS component, called HsiF.
HsiF is also called TssE (Hood etal., 2010), but we use the Hsi
nomenclature as previously described (Filloux et al., 2008),
which matches the nomenclature described for the Rhizobium
leguminosarum T6SS archetype (Bladergroen et al., 2003). We
showthatHsiFproteinsareessentialcomponentsoftheT6SS,
and we further support the hypothesis that this family of
proteins is structurally similar to the T4 phage protein gp25.
Furthermore, our data suggest that HsiF proteins do not
display lysozyme activity, as has been suggested for members
of the gp25-like protein family (Szewczyk et al.,1 9 8 6 ) .I n
agreement with this observation, we demonstrate that HsiF is
localized in the P. aeruginosa cytoplasm.
METHODS
Bacterial strains and growth conditions. Bacterial strains used in
this study are described in Supplementary Table S1. P. aeruginosa
strains were grown in tryptone soy broth (TSB; Difco) supplemented
with antibiotics as appropriate (carbenicillin, 150 mg ml
21; strep-
tomycin, 2000 mg ml
21). Escherichia coli strains were grown in Luria–
Bertani (LB; Difco) broth supplemented with antibiotics as appro-
priate (kanamycin, 50 mg ml
21; ampicillin, 100 mg ml
21; streptomycin,
50 mg ml
21).
Antibodies and reagents. Polyclonal anti-VgrG1a, anti-VgrG1b
and anti-Hcp1 have been described previously (Hachani et al., 2011)
and were used at a dilution of 1:1000. Monoclonal anti-RNA
polymerase (RNAP) antibody (W0023, Neoclone), directed against
the beta subunit of RNAP, was used at a dilution of 1:1000. Polyclonal
anti-HsiF1 was used at a dilution of 1:500 and obtained as described
above.Polyclonal anti-DsbA wasused at a dilutionof1:10000 andwas
kindly provided by Dr Karl E. Jaeger (IMET, Ju ¨lich, Germany).
Polyclonal anti-XcpY antibody has been described previously (Michel
et al., 1998) and was used at a dilution of 1:1000. Secondary antibodies
werepurchasedfromSigmaandusedata dilutionof1:5000 [goatanti-
rabbit–horseradish peroxidase (HRP) (A6154); rabbit anti-mouse–
HRP (A 9044)]. Western blots were developed using SuperSignal West
PicoChemiluminescentSubstrate (Pierce)and a Fuji LAS-3000imager.
PCRs for cloning purposes were carried out using High Fidelity DNA
polymerase (Roche).
Plasmids. Plasmids used in this study are summarized in Supple-
mentary Table S2. The expression plasmids pET-F1, encoding an N-
terminal 66His fusion protein of HsiF1, and pGEX-F3, encoding an
N-terminal glutathione S-transferase (GST) fusion of HsiF3, were
constructed as follows. hsiF1 and hsiF3 were amplified from genomic
DNA of P. aeruginosa PAO1 by PCR using oligonucleotide pairs
OAL92/94 and OAL99/100 (Supplementary Table S3), respectively,
adding appropriate restriction sites to the respective ends of the PCR
product. Inserts were confirmed by sequencing and inserted into
pET28a (Stratagene) and pGEX4T1 (GE Healthcare), respectively. The
complementation plasmid pHsiF1 was constructed by amplification
of hsiF1 from P. aeruginosa PAK genomic DNA using OAL138/139,
adding EcoRI and BamHI restriction sites to the respective ends of the
PCR product for ligation into pBBR1MCS-4. The hsiF1E105A allele
was engineered by site-directed mutagenesis using the QuikChange
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turer’s manual, employing primers OAL147/OAL148 containing the
desired mutation. The plasmid pKNG-DhsiF1 was constructed as
follows. Overlapping gene segments were amplified from P. aeruginosa
PAK genomic DNA upstream and downstream of hsiF1 using
oligonucleotide pairs OAL65/66 and OAL67/68, and were merged by
overlapping PCR usingprimers OAL65/68.The resulting DNA fragment
was cloned into pKNG101 using ApaIa n dBamHI restriction sites. All
constructs were confirmed by sequencing (GATC Biotech) prior to use.
Construction of deletion mutants in P. aeruginosa. P. aeruginosa
deletion mutants were constructed as described previously (Vasseur et
al., 2005) using the suicide plasmid pKNG101 (Kaniga et al., 1991).
To create the PAKDretSDhsiF1 mutant strain, pKNG-DhsiF1 was
introduced into P. aeruginosa PAKDretS. Clones in which the double
recombination events occurred, resulting in the deletion of hsiF1,
were selected on sucrose-containing plates as described elsewhere
(Kaniga et al., 1991). Deletion of hsiF1 was verified by PCR using
primers upstream and downstream of hsiF1 (OAL87/88).
Production of antibody directed against HsiF1. Expression of the
66His–HsiF1 fusion protein was induced from pET-F1 using 1 mM
IPTG (Sigma) in E. coli Rosetta2 BL21(DE3) for 6 h at 37 uC before
cells were pelleted by centrifugation. Inclusion bodies containing the
recombinant 66His–HsiF1 were isolated from bacterial pellets by
sonication on ice in lysis buffer (10 mM Tris, pH 8.0, 3 mM EDTA)
and subsequent centrifugation. Inclusion bodies were washed with
lysis buffer and dissolved in 8 M urea, pH 8.0, for 1 h at room
temperature. Cell debris was removed by ultracentrifugation at
70000 g for 1 h at 4 uC, and supernatants were applied to nickel-
nitrilotriacetic acid (Ni-NTA) columns (HiTrap, Amersham
Biosciences) for purification of His–HsiF1 by imidazole gradient.
Eluted 66His–HsiF1 was dialysed against 10 mM Tris, pH 8.0, and
injected into rabbits for antibody production (Eurogentec).
HsiF3 production and purification. Expression of GST fusion
protein was induced from pGEX-F3 using 1 mM IPTG (Sigma) in E.
coli Rosetta2 BL21(DE3) for 16 h at 20 uC before cells were pelleted
by centrifugation. Pellets were suspended in lysis buffer [50 mM
HEPES, 200 mM NaCl, 5–10 mM DTT, 2 mM EDTA, supplemented
with Complete Protease Inhibitor Cocktail (Roche)] and lysed by
passage through a French press. The soluble fraction containing GST–
HsiF3 was applied to 3 ml Glutathione Sepharose High Performance
resin packed into an XK 16/20 column (GE Healthcare), at
0.1 ml min
21. The resin was washed with 20 column volumes of
lysis buffer and five column volumes of gel filtration buffer (50 mM
HEPES, 200 mM NaCl, 2 mM DTT) before overnight incubation at
4 uC with 200 U thrombin to cleave the GST tag. HsiF3 was further
purified by gel filtration [applied in gel filtration buffer to a HiLoad
16/60 Superdex 75 column (GE Healthcare)], concentrated using a
4 ml Amicon Ultra Centrifugal filter device (Millipore) and used
subsequently in a biochemical assay to analyse its enzymic activity.
Preparation of supernatant from P. aeruginosa culture. P.
aeruginosa strains were grown in TSB overnight, subcultured to
OD600 0.1, and grown to early stationary phase at 37 uC under
agitation. Cells were separated from culture supernatants by cen-
trifugation of bacterial cultures at 4000 g at 4 uC. Cells were directly
resuspended in 16 Laemmli buffer (Laemmli, 1970). Proteins
contained in the culture supernatant were precipitated using 6 M
TCA at a final TCA concentration of 10%. Protein pellets were
washed in 90% acetone, dried, and resuspended in 16 Laemmli
buffer for analysis by SDS-PAGE. Samples were boiled at 95 uC for
10 min before SDS-PAGE.
Subcellular fractionation of P. aeruginosa. P. aeruginosa strains
were grown overnight in TSB, and subcultures were grown to early
stationary phase the following day. Cells were collected by
centrifugation and resuspended in 10 mM Tris, pH 8.0, supplemen-
ted with Complete Protease Inhibitor Cocktail (Roche) and 1 mM
EDTA, before cells were lysed by sonication (3630 s, amplitude of
35%) using a Vibra-Cell ultrasonic processor (Sonics). Intact cells
were removed by centrifugation at 4000 g for 5 min at 4 uC. Soluble
and membrane fractions were separated by centrifugation at
100000 g for 1 h at 4 uC before analysis by SDS-PAGE.
Pseudomonas spheroplasts (cytosol+membranes) and periplasmic
fraction were obtained as described elsewhere (Lory et al., 1996).
Briefly, cells were collected by centrifugation and washed in 50 mM
Tris, pH 7.6. Cell pellets were then suspended in 0.2 M MgCl2,
50 mM Tris, pH 7.6, and incubated for 30 min at 30 uC, 5 min on ice
and 15 min at room temperature. Spheroplasts were separated from
the periplasmic fraction by centrifugation at 8000 g for 10 min at
4 uC. Samples were suspended in Laemmli buffer and boiled at 95 uC
before analysis by SDS-PAGE.
Bioinformatic analysis. Structural prediction and modelling of
secondary and tertiary structures were carried out using Phyre (http://
www.sbg.bio.ic.ac.uk/phyre) (Kelley & Sternberg, 2009). Tertiary
structures were visualized using PyMOL. Amino acid sequence
alignments were performed using web-based CLUSTAL W2 software
(http://www.ebi.ac.uk/Tools/msa/clustalw2) and edited using GenDoc
freeware. Phylogenetic analysis was carried out using http://www.
phylogeny.fr. The neighbour-joining tree was computed with 100
bootstrap replicates. Tree rendering was carried out using TreeDyn.
Assessment of lysozyme activity. Lysozyme activity of recombin-
ant HsiF3 was assessed using a lysozyme assay described elsewhere
(Nakimbugwe et al., 2006). Briefly, 30 ml recombinant HsiF3 (5, 0.5
or 0.05 mg ml
21) was incubated with 270 ml Micrococcus lysodeikticus
suspension [0.35 mg ml
21 lyophilized M. lysodeikticus (ATCC 4698,
Sigma), 0.5 mg BSA ml
21 (Sigma) in 10 mM potassium phosphate
buffer, pH 7.2].A3 0ml volume of hen egg white lysozyme (HEWL;
96000 U mg
21, Sigma) was used as a positive control at 0.5 mg ml
21,
while 30 ml potassium phosphate buffer functioned as a negative
control. Cell lysis was monitored as the decrease in turbidity of the
enzyme/substrate mixture at 595 nm at 37 uC every 5 min over 1 h
using a FLUOstar Optima microplate reader (BMG Labtech).
Lysozyme activity was further analysed using an EnzChek Lysozyme
Assay kit (E-22013, Molecular Probes) according to the manufac-
turer’s manual. A 50 ml volume of recombinant HsiF3 (concentration
range 5–0.035 mg ml
21), HEWL (dilutions as indicated from a stock
of 1000 U ml
21, provided by the kit), P. aeruginosa cell lysate
(undiluted) or assay buffer (negative control) was incubated with
50 ml fluorescently labelled M. lysodeikticus at 37 uC for 1 h, and
fluorescence (excitation 494 nm, emission 518 nm) was measured
using a FLUOstar Optima microplate reader at 5 min intervals.
Pseudomonas cell lysate was prepared from cells grown for 5 h with
the appropriate antibiotics in TSB. Cells were pelleted, resuspended in
lysis buffer (50 mM Tris, pH 8.0, Complete Protease Inhibitor
Cocktail) and lysed by sonication for 4630 s at an amplitude of
35% (Vibra-Cell, Sonics). The cell extract was clarified by
centrifugation at 16000 g for 5 min at 4 uC.
RESULTS
HsiF is a conserved T6SS component of the gp25-
like protein family
The P. aeruginosa hsiF gene is one of 12–15 genes
conserved in T6SS clusters (Filloux et al., 2008). There
are three paralogues in P. aeruginosa, hsiF1 (PA0087), hsiF2
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three T6SS clusters, H1-T6SS, H2-T6SS and H3-T6SS,
respectively. The three P. aeruginosa HsiF proteins range
from 135 to 169 aa in size, and display from 22.9% (HsiF1
and HsiF3) to 29.9% (HsiF2 and HsiF3) sequence identity
(Fig. 1a). We compared the P. aeruginosa HsiF amino acid
sequences with several orthologues found in T6SSs from
other bacteria (TIGR03357) (Fig. 1a), including Salmonella
enterica serovar Typhimurium (S. Typhimurium), Shigella
flexneri, Yersinia pestis, Burkholderia thailandensis, V.
cholerae and E. coli. The alignment demonstrated that
two motifs, EPRL and YGL, are highly conserved among
this family of T6SS components, suggesting that they have
an essential role.
Furthermore, NCBI BLAST analysis identified a similarity
between HsiF proteins and proteins of the gp25-like family
(pfam04965) (Fig. 1a), including the archetype gp25
component of the baseplate wedge of the T4 bacteriophage
(Yap et al., 2010), and the gp25-like protein encoded in a
prophage region of the Geobacter sulfurreducens genome
(GSU0986). The three HsiF proteins show similarity to
gp25 at the amino acid sequence level, ranging from 16%
(HsiF1 and gp25 from T4 phage) to 21.4% (HsiF2 and
gp25 from T4 phage) identity. The amino acid sequence
alignment of the HsiF1, HsiF2, HsiF3 and gp25-like
proteins (Fig. 1a) shows a number of highly conserved
residues. In particular, the EPRL motif is conserved
between HsiFs and gp25-like proteins, while the YGL
Fig. 1. Amino acid sequence comparison and phylogenetic relationship among members of the gp25 family. (a) Identification of
conserved residues in members of the gp25-like protein family. Amino acid sequence alignments of HsiF proteins of P.
aeruginosa (HsiF1/PA0087, HsiF2/PA1659 and HsiF3/PA2368), T4 phage gp25, G. sulfurreducens GSU0986 and HsiF
homologues found in other Gram-negative bacteria associated with a T6SS gene cluster (CLUSTAL W2, GeneDoc). Different
levels of shading indicate the level of conservation (100%, black; .80%, dark grey; .60%, light grey; ,60%, white). The
amino acid position is indicated at the beginning and the end of each line. (b) Phylogenetic analysis of gp25-like proteins.
Neighbour-joining tree based on HsiF proteins, gp25 of the T4 bacteriophage, GSU0986 of G. sulfurreducens and several
HsiF orthologues found in Gram-negative bacteria that are associated with T6SS gene clusters. Indicated bootstrap values
correspond to 100 replicates. Phylogenetic analysis was carried out using http://www.phylogeny.fr.
Type VI secretion system in Pseudomonas aeruginosa
http://mic.sgmjournals.org 3295motif is not conserved among all members of this family
(Fig. 1a). The YGL motif is absent both in the T4 phage
gp25 and in the gp25-like protein encoded in a prophage
region of the G. sulfurreducens genome (Fig. 1a). In these
proteins, YGL is replaced by an FGC motif, which could be
a hallmark of this subfamily. These observations confirmed
that the EPRL motif is conserved in all gp25-like proteins,
whereas the YGL motif is a hallmark of gp25-like
components involved in T6SS.
Phylogenetic analysis confirmed that T6SS members of the
gp25 family and the phage-associated gp25 proteins have a
common ancestor, but are distinct and found in separate
branches of the tree (Fig. 1b). Furthermore, the phylogen-
etic analysis illustrates that the HsiF proteins of P.
aeruginosa are not closely related to each other. Instead,
each P. aeruginosa HsiF is found to be closely related to a
homologue from another Gram-negative bacterium (Fig.
1b). For example, HsiF2 shows only 25.5% identity to
HsiF1, but 33.8% identity to VCA0109 of V. cholerae, and
HsiF1 displays 22.9% identity to HsiF3, but 45.8% identity
to BTH_II0261 of B. thailandensis. This observation also
suggests that each P. aeruginosa T6SS may have a distinct
function.
Role of HsiF in VgrG and Hcp secretion
Generally, T6SS gene clusters are not expressed in
laboratory conditions, but are induced in the host (Das
et al., 2000; Mattinen et al., 2007; Parsons & Heffron,
2005). The P. aeruginosa H1-T6SS cluster has been
extensively studied, since its expression is induced in a
mutant deleted for the retS gene (PAKDretS), which
encodes a sensor kinase (Mougous et al., 2006). The H1-
T6SS system has been shown to be involved in secretion of
Hcp1 (PA0085), VgrG1a (PA0091), VgrG1c (PA2685)
(Hachani et al., 2011; Hood et al., 2010; Mougous et al.,
2006) and the Tse1–3 proteins (Hood et al., 2010). Among
the 22 genes of the H1-T6SS cluster, only clpV1 has been
shown to be required for Hcp, VgrG and Tse secretion. To
identify the role of HsiF1 in the T6SS, a deletion of the
hsiF1 gene was engineered in a PAKDretS background,
resulting in PAKDretSDhsiF1. Secretion of VgrG1a, VgrG1b
and VgrG1c as well as Hcp1 was analysed by SDS-PAGE
and immunoblotting (Fig. 2). VgrG1a, VgrG1b and
VgrG1c were detected in PAKDretS cell lysate by an
antibody raised against VgrG1a (Hachani et al., 2011),
confirming induction of the H1-T6SS genes (Fig. 2, top
panel, lane 1). Using this antibody, only VgrG1a and
VgrG1c, but not VgrG1b, were detectable in culture
supernatants (Fig. 2, top panel, lane 4), which is in
agreement with our previous study (Hachani et al., 2011).
The deletion of hsiF1 severely reduced secretion of VgrG1a
and VgrG1c, which were poorly recovered in the culture
supernatant of PAKDretSDhsiF1 (Fig. 2, top panel, lane 6).
Secretion of Hcp1 was also abolished in the absence of
hsiF1 (Fig. 2, second panel, lane 6), whereas Hcp1 was
detectable in the cells (Fig. 2, second panel, lane 3). We
analysed VgrG1b secretion using an antibody raised
against VgrG1b (Hachani et al., 2011). This antibody
recognizes not only intracellular but also extracellular
VgrG1b (Hachani et al., 2011). In contrast to VgrG1a and
VgrG1c, VgrG1b secretion was unaffected by deletion of
hsiF1 (Fig. 2, third panel, lane 6). This observation is in
agreement with our previous report, which showed that
secretion of VgrG1b is T6SS-independent, as it is still
secreted in a clpV1 deletion mutant (Fig. 2, third panel,
lane 5) and a clpV1/2/3 triple mutant (Hachani et al., 2011;
Hood et al., 2010). In all cases, we assessed the absence of
cell lysis by monitoring the localization of RNAP (Fig. 2,
bottom panel). In conclusion, our data demonstrate that
HsiF is an essential component for T6SS-dependent
secretion in P. aeruginosa.
Structure prediction for HsiF proteins
Information about HsiF structure was obtained using
bioinformatic tools such as the Phyre fold prediction software
Fig. 2. HsiF1 is essential for H1-T6SS
function. PAKDretS, PAKDretSDclpV1 and
PAKDretSDhsiF1 were grown in TSB for 5 h.
Whole-cell lysates (lanes 1–3) and 10
concentrated Pseudomonas culture supernat-
ant (lanes 4–6) were analysed by SDS-PAGE
and Western blotting using polyclonal anti-
bodies directed against VgrG1a (first row),
Hcp1 (second row) or VgrG1b (third row).
Monoclonal anti-RNAP antibody was used to
control for cell lysis in the supernatant fraction
(fourth row). Molecular mass markers are
indicated on the right (kDa). The positions of
VgrG1a, VgrG1b, VgrG1c, Hcp1 and RNAP
are indicated on the left.
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that HsiF proteins resemble the solved structure of the gp25-
like protein encoded by GSU0986 on the G. sulfurreducens
genome. On this bacterial genome, two genes can be
identified thatencode gp25-like proteins: GSU0986 (encoding
NP_952040.1) and GSU0430.W h i l eGSU0430 is part of a
characteristic T6SS cluster (locus AE017080A), GSU0986 is
not associated with T6SS genes. Instead, several phage-related
genes can be identified in the vicinity of GSU0986,s u c ha s
GSU0983, annotated as a phage-related baseplate assembly
protein, and GSU0987, annotated as a baseplate J-like protein
found in the P2 bacteriophage. Thus, GSU0986 encodes a
gp25-like protein, which is more closely related to gp25 of the
T4 phage than to gp25-like components encoded by T6SS
gene clusters. This observation is supported by the lack of the
YGL motif in GSU0986 (Fig. 1a) and its close phylogenetic
relationship with gp25 of the T4 phage (Fig. 1b).
The predictions for the tertiary structure of HsiF1, HsiF2
and HsiF3 were obtained from fold recognition algorithms
with high statistical significance (95–100% precision,
Supplementary Fig. S2). The gp25-like protein from Geo-
bacter, which we refer to as GSU0986, adopts a compact fold
and belongs to the a/b fold family (Fig. 3a, c). The GSU0986
fold consists of a three-stranded anti-parallel b-sheet with
one side surrounded by two long anti-parallel a-helices and
a third smaller a-helix. Homology models of HsiF proteins,
such as HsiF3 (Fig. 3b), are very similar to the GSU0986
structure. However, theHsiF1 structure predictionis slightly
more divergent, especially within the b-domain, where two
b-strands instead of three are predicted (Supplementary Fig.
S2). This is likely due to amino acid sequence insertions in
HsiF1 compared with HsiF2 and HsiF3. Another striking
feature in the fold of the GSU0986 and HsiF proteins is an
exposed loop structure that links a1 and a2 (Fig. 3a, b),
Fig. 3. Homology modelling of HsiF homologues based on the crystal structure of GSU0986 of G. sulfurreducens. (a) Ribbon
representation of the crystal structure of Geobacter GSU0986 (PDB2ia7), showing the unusual loop conformation between a1
and a2. N and C termini are labelled. (b) Ribbon representation of the HsiF3 homology model based on GSU0986 as an
exemplar of the HsiF homologues. (c) Ribbon representation of GSU0986, highlighting identical residues between GSU0986
and HsiF homologues. The E85-P86-R87 forms a tight turn between a3 and b1, with E85 and R87 forming a salt bridge (dotted
black line). This turn is essential for stabilizing the positions of a1, a3 and b1 and in establishing the overall gp25 fold. Other
conserved residues not labelled include W84 and I88, both of which form hydrophobic interactions that also stabilize the
GSU0986 fold. (d) Representations of the electrostatic surface potential for GSU0986/gp25 and HsiF3, with positive potential
shown in blue and negative in red. Note the striking striated pattern of positive and negative surface potential for HsiF3 versus
GSU0986/gp25. All figures were made using PyMOL (http://www.pymol.org).
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~42 A ˚6~33 A ˚6~22 A ˚.
The main sequence identities between the HsiF homo-
logues, T4 phage gp25 and GSU0986 are residues E85, P86
and R87 (gp25-like GSU0986 numbering) (Fig. 1a). These
residues form part of a short, tight turn between a3 and b1,
with E85 forming a salt bridge with R87, stabilizing the
position of a1 and the base of the loop (Fig. 3c). Other
sequence identities relate to conserved hydrophobic core
residues. In terms of surface features, an electrostatic
surface representation of the homology models compared
with GSU0986 shows some significant differences; for
example, the external surface of the b-sheet, where HsiF3
shows a striking striated surface of negative and positive
potential compared with GSU0986 (Fig. 3d). These
differences could relate to different adaptations of HsiF
homologues to specifically associate with their respective
T6SSs.
A conserved glutamate residue is essential for
HsiF function
The conservation of a glutamate residue within the EPRL
motif of the gp25 family, and its predicted role in the gp25-
like GSU0986 structure (E85) to form a salt bridge with
R87, supports the importance of this residue in protein
function. To assess the role of the E105 residue in HsiF1, a
mutation was introduced into the hsiF1 gene, resulting
in the E105A substitution. The new hsiF1 allele, encod-
ing HsiF1E105A, was cloned in pBBR1MCS-4, yielding
pHsiF1E105A. The wild-type allele of the hsiF1 gene was
also cloned in the broad-host-range expression vector
pBBR1MCS-4, yielding pHsiF1. A complementation experi-
ment using pHsiF1 readily restored secretion of VgrG1a and
VgrG1c, as well as Hcp1, in the PAKDretSDhsiF1 mutant
strain (Fig. 4a). In contrast, production of HsiF1E105A from
pHsiF1E105A did not fully restore secretion of Hcp1, VgrG1a
or VgrG1c (Fig. 4a). Both HsiF1 and HsiF1E105A were
produced at similar levels, as demonstrated by Western blot
analysis using an antibody directed against HsiF1 (Fig. 4b).
In conclusion, our data showed that the E105 residue is
essential for HsiF1 function, as could be predicted from its
central position in the HsiF fold (Fig. 3c).
HsiF proteins do not display detectable lysozyme
activity
In 1986, Szewczyk and co-workers identified gp25 of the T4
phage as a 15 kDa component responsible for lysozyme
activity in cells infected with a T4 bacteriophage (Szewczyk
et al., 1986). Since then, proteins annotated as members of
this family (gene 25-like lysozyme; pfam04965) have been
assumed to possess lysozyme activity, but no further
experimental evidence has supported this assumption to
date. We investigated whether HsiF proteins, which are
members of the gp25-like protein family, exhibit lysozyme
Fig. 4. The conserved glutamate residue E105 is required for HsiF1 function. (a) PAKDretS (lanes 1 and 5), PAKDretSDhsiF1
strains containing pBBR1MCS-4 (labelled MCS-4, lanes 2 and 6), pHsiF1 (lanes 3 and 7) and pHsiF1E105A (lanes 4 and 8), as
indicated, were grown to late exponential phase. Whole-cell lysates (lanes 1–4) and 10 concentrated Pseudomonas culture
supernatant (lanes 5–8) were analysed by SDS-PAGE and Western blotting using polyclonal anti-VgrG1a and anti-Hcp1
antibodies. Molecular mass markers are shown on the left (kDa). (b) HsiF1 and HsiF1E105A are produced at similar levels in P.
aeruginosa. PAKDretS (lane 1) and PAKDretSDhsiF1 containing pBBR1MCS-4 (lane 2), pHsiF1 (lane 3) or pHsiF1E105A (lane
4) were grown to late exponential phase, and production of HsiF1 and HsiF1E105A was analysed by Western blotting using
polyclonal anti-HsiF1 antibody. Chromosomal levels of HsiF1 as well as HsiF1 and HsiF1E105A produced from pHsiF1 and
pHsiF1E105A, respectively, are indicated by arrows. HsiF1 and HsiF1E105A contain a C-terminal 6His tag, and the
corresponding band therefore runs slightly more slowly than the chromosomally expressed HsiF. Molecular mass markers are
indicated on the right (kDa). The band below the 15 kDa marker is a non-specific cross-reacting protein.
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aeruginosa hsiF genes were cloned in plasmids pET28a and
pGEX4T1 (Supplementary Table S2, see Supplementary
Methods), allowing the production of HsiF proteins
carrying an N-terminal His or GST tag, respectively. The
recombinant plasmids were introduced into E. coli Rosetta2
BL21(DE3). Cells were grown and lysed, and the soluble
fraction was isolated by centrifugation, as described in
Methods. The soluble and insoluble fractions were analysed
by SDS-PAGE and Coomassie staining (Supplementary Fig.
S1). In all cases, HsiF1 and HsiF2 remained mainly in the
insoluble fraction, whereas HsiF3 proved to be soluble
(Supplementary Fig. S1b). It is worth mentioning that the
most insoluble protein, HsiF1, displayed significant struc-
tural variability in the b-domain as compared with HsiF2
and HsiF3 (Supplementary Fig. S2), which could explain its
different biochemical behaviour.
Further biochemical analyses were carried out using GST–
HsiF3, which was purified with a high yield by affinity
chromatography (Fig. 5a, see Methods). The GST moiety
was removed using thrombin, and the potential lysozyme
Fig. 5. Purified HsiF3 protein does not exhibit detectable lysozyme activity. (a) Recombinant HsiF3 used for in vitro analysis.
HsiF3 was expressed and purified as described in Methods. Purified HsiF3 was analysed by SDS-PAGE and stained by
Coomassie blue. (b) Recombinant HsiF3 (5, 0.5 or 0.05 mg ml
”1), HEWL (0.5 mg ml
”1) or assay buffer was incubated with a
suspension of M. lysodeikticus in 96-well plates. The decrease in turbidity was monitored at 595 nm over 60 min at 37 6C. (c)
HEWL (bar chart to the left; dilution series from left to right 50 to 0.375 U per assay point) or recombinant HsiF3 (bar chart to
the right; dilution series 5 to 0.035 mg ml
”1 final enzyme concentration per assay point) was incubated with fluorescently
labelled M. lysodeikticus for 60 min at 37 6C before fluorescence was measured as described in Methods. Emission of
fluorescence is represented by arbitrary fluorescence units (a.f.u.). One unit of HEWL is defined by the manufacturer as the
amount of enzyme required to produce a change in the A450 of 0.001 U min
”1 at pH 6.24 and 25 6C, using a suspension of M.
lysodeikticus as the substrate.
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freeze-dried M. lysodeikticus (Fig. 5b). HEWL was used as a
positive control in all assays. Lysozyme activity resulting in
cell lysis was monitored as the decrease in turbidity of the
enzyme/substrate mixture (Fig. 5b). As expected, 0.5 mg
HEWL ml
21 cleared the M. lysodeikticus suspension within
30 min (Fig. 5b). However, incubation of substrate with
concentrations of recombinant HsiF3 ranging from 0.05 to
5m gm l
21 did not result in a decrease of turbidity over an
incubation time of 60 min, indicating that recombinant
HsiF3 does not exhibit lytic activity.
Since the strength of lysozyme activity per milligram of
HsiF is unknown and a weak lytic activity of HsiF3 might
have been missed in the previous assay, a more sensitive
assay using fluorescently labelled M. lysodeikticus was
performed, recording fluorescence emission as a measure
of activity (Fig. 5c). While an increase in fluorescence was
recorded when the substrate was incubated with increasing
concentrations of HEWL, no change in fluorescence was
detectable after incubation of HsiF3 with labelled M.
lysodeikticus for 60 min.
If HsiF proteins had lysozyme activity, the P. aeruginosa
peptidoglycan would be the most likely substrate for these
proteins. Accordingly, chloroform extracts of P. aeruginosa
peptidoglycan were prepared and used as a potential
substrate for both HEWL and HsiF3. In agreement with
our previous findings, no hydrolysis of P. aeruginosa
peptidoglycan was observed with HsiF3 in contrast to
HEWL (Supplementary Fig. S3).
Since it could not be excluded that HsiF3 activity was lost
during the purification procedure, extracts of PAKDretS
(induced production of HsiF1) and PAKDretSDhsiF1 (no
HsiF1 produced) were compared for lysozyme activity
using fluorescently labelled M. lysodeikticus (Fig. 6). An
increase of detectable fluorescence was observed over time
with extracts from both strains compared with incubation
with the assay buffer alone. However, no difference in
fluorescence was observed between extracts of PAKDretS
and PAKDretSDhsiF1, suggesting that the observed activity
was HsiF1-independent (Fig. 6a). In order to increase the
amount of HsiF1 produced in P. aeruginosa, we introduced
the hsiF1-overexpressing plasmid pHsiF1 into PAKDret
SDhsiF1. Lysozyme activity in extracts of this strain was
compared with that of extracts of PAKDretSDhsiF1 carrying
the empty vector, using fluorescently labelled M. lysodeikti-
cus, but no significant difference was detected (Fig. 6b). We
Fig. 6. HsiF1 does not exhibit detectable
lysozyme activity when expressed in P. aeru-
ginosa. (a) Cell lysates of P. aeruginosa
PAKDretS and PAKDretSDhsiF1, grown to late
exponential phase as described in Methods,
were incubated with fluorescently labelled M.
lysodeikticus for 50 min at 37 6C, during which
fluorescence was measured every 5 min. Assay
buffer was incubated with M. lysodeikticus as a
negative control. Emission of fluorescence is
represented by arbitrary fluorescence units
(a.f.u.). (b) Cell lysates of P. aeruginosa
PAKDretSDhsiF1 containing pBBR1MCS-4 or
pHsiF1, grown to late exponential phase, were
incubated with fluorescently labelled M. lyso-
deikticus for 60 min at 37 6C, during which
fluorescence was measured every 5 min. Assay
buffer was incubated with M. lysodeikticus as a
negative control. Error bars, SD derived from
triplicates of each assay point. Emission of
fluorescence is represented by a.f.u.
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lysozyme activity.
Finally, we also assessed the ability of HsiF proteins to
hydrolyse the peptidoglycan in the periplasm of E. coli by
engineering fusions of hsiF1, hsiF2 and hsiF3 to the malE
gene, encoding maltose-binding protein (MBP). These
constructions were made using the pMALp2x vector
(periplasmic expression) and the pMALc2x vector (cyto-
plasmic expression) and were introduced into E. coli (see
Supplementary Methods). In similar experiments, Russell
and collaborators have shown that the P. aeruginosa lytic
proteins Tse1 and Tse3 severely affect E. coli growth (Russell
et al., 2011). Here we showed that neither of the HsiF
proteins had a lytic activity when targeted to the E. coli
periplasm, since the growth curve of the recombinant strains
wassimilar tothe growthof the strain containing the cloning
vector or strains expressing HsiF proteins in the cytosol
(Supplementary Fig. S4).
HsiF1 localizes to the cytoplasm of P. aeruginosa
The HsiF proteins do not contain predicted transmem-
brane domains or signal peptides, which suggests that they
are cytoplasmic proteins. The subcellular localization of
HsiF1 was analysed in PAKDretS, i.e. the soluble and
membrane fractions of PAKDretS and PAKDretSDhsiF1
were separated after cell lysis, and protein content was
analysed by SDS-PAGE and immunoblotting. The HsiF1
protein is lacking in the hsiF1 mutant, and was recovered in
the soluble fraction of PAKDretS (Fig. 7a, top panel, lane
3). Similarly, the cytoplasmic RNAP and the periplasmic
DsbA (Urban et al., 2001) proteins were recovered in the
soluble fraction (Fig. 7a, third and fourth panels, lanes 3
and 4). In contrast, the polytopic inner-membrane protein
XcpY (Bleves et al., 1996) was exclusively found in the
membrane fraction (Fig. 7a, second panel, lanes 5 and 6).
Since HsiF1 is found in the soluble fraction, we further
tested whether HsiF1 is a cytoplasmic or periplasmic
protein. Spheroplasts of PAKDretS and PAKDretSDhsiF1
were prepared, the periplasmic fraction was isolated, and
the protein content was analysed by SDS-PAGE and
immunoblotting (Fig. 7b). No cell lysis or periplasmic
leakage had occurred during the fractionation procedure,
since RNAP was found associated with the spheroplasts
(Fig. 7b, third panel, lanes 5 and 6) and DsbA with the
periplasm (Fig. 7b, bottom panel, lanes 3 and 4). We
observed that HsiF1 was associated with the spheroplasts
(Fig. 7b, top panel, lane 5) and that no HsiF1 protein was
detectable in the periplasm (Fig. 7b, top panel, lane 3).
In order to further support the hypothesis of the
cytoplasmic localization of HsiF1, an hsiF1::phoA fusion
was engineered using the pPHO7 vector (Gutierrez &
Devedjian, 1989). The recombinant plasmid was intro-
duced into the PAKDretS strain, and alkaline phosphatase
activity was monitored on plates containing the alkaline
phosphatase substrate 5-bromo-4-chloro-3-indolyl phos-
phate (BCIP). The P. aeruginosa colonies harbouring
pHsiF1::phoA remained white on this plate, suggesting
that HsiF1 was not able to target PhoA to the P. aeruginosa
periplasm. Instead, the strain containing a dsbA::phoA
fusion resulted in blue colony formation (Supplementary
Fig. 7. HsiF1 does not localize to the periplasm of P. aeruginosa.
Subcellular localization of HsiF1 was analysed in PAKDretS and
PAKDretSDhsiF1 grown to late exponential phase. Cell fractions
were analysed by SDS-PAGE and immunoblotting. Successful
fractionation was verified using antibodies directed against
periplasmic DsbA (bottom row), the inner-membrane protein
XcpY (second row) and cytosolic RNAP (third row). HsiF1 was
detected using polyclonal anti-HsiF1 antibody (first row). (a) HsiF1
localizes to the soluble fraction in P. aeruginosa. The soluble (lanes
3 and 4) and insoluble fractions (indicated as membranes, lanes 5
and 6) of PAKDretS and PAKDretSDhsiF1 were obtained by
sonication followed by ultracentrifugation as described in Methods,
and were analysed by immunoblotting using the controls described
above. (b) HsiF1 does not localize to the periplasm in P.
aeruginosa. Western blot analysis of whole-cell lysate (lanes 1
and 2), periplasmic fraction (lanes 3 and 4) and spheroplasts
(representing a combination of cytosol and bacterial membranes;
lanes 5 and 6) was performed using the antibodies described
above.
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2001). Finally, a strain encoding an hcp1::phoA fusion also
displayed blue colonies on these plates (Supplementary Fig.
S5). Hcp1 has been shown to localize within most of the P.
aeruginosa subcellular compartments, including the peri-
plasm (Mougous et al., 2007).
In Gram-negative bacteria, the peptidoglycan, which is a
well-described substrate for lysozymes, is located in the
periplasm. We thus concluded that HsiF1 is a cytoplasmic
protein and therefore has no access to periplasmic
peptidoglycan, which is in agreement with the lack of
detectable lysozyme activity.
DISCUSSION
The discovery of a novel secretion system in Gram-negative
bacteria, now referred to as the T6SS, was earlier associated
with the identification of two genes encoding inner-
membrane proteins with similarity to IcmF and DotU
(Das & Chaudhuri, 2003). These two proteins have been
described as involved in the function of another secretion
system, namely the type IV secretion system (T4SS).
However, the newly identified icmF and dotU-like genes
belonged to gene clusters with no other similarity to T4SS
genes. Therefore, the set of 12–15 conserved genes
associated with the icmF/dotU-like genes constituted the
T6SS clusters. Among these, one gene was identified as a
clpV-like gene encoding a member of the AAA
+ ATPase
family. Several other genes encode proteins with no
characteristic features, such as a transmembrane domain,
a signal peptide or anything suggesting that they may be
extracytoplasmic proteins. Finally, one gene encodes a
putative outer-membrane lipoprotein, whose localization
was later confirmed in enteroaggregative E. coli (Aschtgen
et al., 2008).
A significant step forward in the conceptualization of the
T6SS mechanism came from structural predictions, which
identified similarities between two core components of the
T6SS, VgrG and Hcp, and components of the bacterio-
phage T4 tail structure. In brief, the T4 phage is composed
of a head that contains the genetic material. The phage
tail includes a tube through which DNA passes during
injection. A tail sheath surrounds the tail tube and
generates the contraction that promotes the DNA injec-
tion. At the tip of the tube, a hub, or tail spike, is found,
which is known to contribute to the puncturing of the
bacterial membrane, allowing the tail tube to penetrate into
the cell. Finally, the tail spike is surrounded by a structure
called the wedge, and together these form the baseplate. All
the parts described above are made through the assembly
of a large number of phage gene products (gp) assembled
as homo- or hetero-multimeric complexes (Rossmann
et al., 2004). The T4 phage assembly process is an ordered
mechanism, in which the formation of the baseplate is
required for further assembly and polymerization of the tail
tube (polymer of gp19) and the tail sheath (polymer of
gp18) (Leiman et al., 2010). The assembly of the baseplate
follows a specific order. For example, the baseplate wedge is
made of seven different proteins, namely gp11, gp10, gp7,
gp8, gp6, gp53 and gp25, which interact sequentially in
the order indicated here (Yap et al., 2010). Furthermore,
six assembled wedges will spontaneously associate to sur-
round the hub, which includes among others gp27 and
gp5, resulting in the formation of a hexagonal baseplate
(Kostyuchenko et al., 2003).
The T6SS component Hcp has been shown to display
structural homology to the tail tube component gp19, and
assembles into an equivalent structure in vitro (Ballister
et al., 2008; Leiman et al., 2009). The VgrG protein has
been proposed to be a combination of gp5 and gp27, which
form the puncturing device of the T4 phage hub (Leiman
et al., 2009; Pukatzki et al., 2007). The trimeric assembly of
gp27–gp5 results in the formation of a so-called cell-
puncturing device. It should be noted that gp5 has three
domains, which are from the N to the C terminus the
oligosaccharide-binding fold (OB fold), a lysozyme domain
anda C-terminalb-helixdomain.InVgrG proteins,thegp5-
like region lacks the lysozyme domain, and the predicted OB
fold is directly fused to the b-helix domain. Importantly, in
case of theT4 phage, thelysozyme domain of gp5is required
for the entry process in hydrolysing the peptidoglycan
contained in the periplasm and subsequently allowing
penetration of the tail tube (Takeda et al., 1998). This
localized disruption of the peptidoglycan does not result in
cell lysis and therefore the phage can inject DNA in a living
cell that will support multiplication and assembly of phage
progenies. Once the progenies are assembled, another phage
lysozyme, encoded by gene e (Matthews & Remington,
1974), is responsible for global peptidoglycan hydrolysis, cell
burst and release of newly synthesized virions.
A hypothesis that has resulted from these observations is
that the T6SS is an inverted puncturing device, in which
VgrG proteins could be used to perforate the bacterial cell
envelope from the inside to the outside, allowing elongation
oftheHcptube and thereleaseofgenuinesubstratesintothe
extracellular medium. This hypothesis is attractive, since no
integral outer-membrane components have been identified
in the T6SS and using a puncturing mechanism will thus
bypass the requirement for an outer-membrane channel. If
the puncturing of the bacterial cell envelope involves VgrG,
the lack of the lysozyme-like domain in these proteins, as
compared with the T4 phage gp5 protein, prompted us to
hypothesize that another component of the T6SS system
could play this role. A study from 1986 reported that the T4
phage baseplate component gp25 is a 15 kDa lysozyme
(Nakagawa et al., 1985; Szewczyk et al., 1986). In those
studies it was found that lysozyme activity could be purified
from bacterial cells infected with phage particles. When
comparing the occurrence of this activity in various genetic
backgrounds,a15 kDalyzosyme-dependentactivitywasstill
found in extract resulting from infection with phages
mutated in gene e or gene 5, but this activity was lost in a
mutant in gene 25.
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served T6SS components, exemplified here by HsiF from P.
aeruginosa, belongs to the gp25 family. However, we
showed in a variety of assays that HsiF does not exhibit
lysozyme activity. In order to further address this issue, we
hypothesized that if HsiF had any lysozyme activity it
should be targeted to the peptidoglycan-containing peri-
plasm. Interestingly, we observed that HsiF1 is located in
the cytoplasmic fraction, out of reach of an interaction
with the peptidoglycan. From these data, we suggest that
HsiF-like proteins, and likely the gp25 family, do not
possess lysozyme activity. Although HsiF does not seem to
interact with the peptidoglycan, it has been shown that
other T6SS components play a role in assembly of the
secretion system into the bacterial cell wall, in particular in
anchoring the secretion system to the peptidoglycan layer
(Aschtgen et al., 2010a, b).
Importantly, it has been shown that gp25 is a structural
component of the phage tail, and that the formation of the
baseplate structure requires gp25 (Yap et al., 2010), which
is likely to be independent of any putative lysozyme
activity. In the predicted structure of HsiF proteins, we
observed that a conserved glutamate residue is central to
establish a salt bridge stabilizing the HsiF fold. By sub-
stituting the glutamate residue with alanine, we obtained a
recombinant protein that wasnot able to restore secretion in
an hsiF mutant. This observation further supports the
contention that HsiF is an essential structural component
of the T6SS, likely similar to gp25 in phage baseplate
formation.
The structural similarity of VgrG, Hcp and HsiF to gp27–
gp5, gp19 and gp25, respectively, suggests that additional
resemblance may exist between the T6SS and the T4 phage
structure. It has been proposed, for example, that VipA and
VipB from the V. cholerae T6SS, which are the P.
aeruginosa HsiB and HsiC homologues (Filloux et al.,
2008), also called TssB and TssC (Hood et al., 2010),
respectively, may have a function related to gp18 that
constitutes the bacteriophage tail sheath (Bo ¨nemann et al.,
2010). This is based more on functional rather than on
structural aspects. Indeed, VipA/B have been shown to be
able to form microtubules, whose assembly/disassembly is
dependent on ClpV ATPase activity. This process may be
compared with the contractile property of the tail sheath
made by the helical arrangement of about 150 subunits of
gp18 (Kostyuchenko et al., 2003).
Our future work will concentrate on elucidating the
existing protein–protein interaction between HsiF and
other components of the T6SS, and try to correlate these
interactions with the known interaction between gp25 and
other components of the baseplate such as gp53 (Yap et al.,
2010). No other obvious homologies could be detected
between T6SS components and gp proteins, and we will
attempt to solve the 3D structure of the Hsi proteins to get
further insights into their role in type VI secretion and
T6SS assembly.
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